Fig. 9: Schematic diagram displaying the regulatory mechanism of YY1 in LN.

YY1 alleviates LN by reducing the Th17/Treg cell ratio through PARP-1 inhibition-induced upregulation of FOXO1 expression, which is attributed to Fra2 inhibition induced by the suppression of IFN-γ promoter activity.